Key result
Imipramine at doses greater than /kg daily was associated with first-degree heart block, suggesting it should be avoided in patients with preexisting cardiovascular disease.
Why the study?
Does high-dose imipramine cause heart block in patients with preexisting cardiovascular disease?
Does high-dose imipramine cause heart block in patients with preexisting cardiovascular disease?
Answers are grounded in this paper and cite their sources.
Imipramine should be used with caution and probably avoided in large doses in patients with preexisting cardiovascular disease due to the risk of first-degree heart block.
To the Editor.— I refer to the article by Kantor et al, entitled "Imipramine-Induced Heart Block" (231:1364, 1975). My colleagues and I have undertaken an extensive look at children receiving therapeutic doses of imipramine and have reported preliminary data (224:902, 1973). Since that time, first-degree heart block has been noted in an occasional patient taking more than 5 mg/kg of imipramine daily. It was noted in our brief paragraph that imipramine not be offered unless there was normal cardiovascular status. I believe that the same prerequisite holds for adults as well as children and that imipramine should probably not be given in large doses when there is any preexisting cardiovascular disease on complete evaluation.
No takes yet. Share an insight, caveat, or question.
Gilbert I. Martin (1975) conducted a letter in Imipramine therapy. Imipramine was evaluated on First-degree heart block. Imipramine at doses greater than /kg daily was associated with first-degree heart block, suggesting it should be avoided in patients with preexisting cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: